New York, NY, United States of America

Server A Ertem

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2015.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Server A Ertem

Introduction

Server A Ertem is a notable inventor based in New York, NY (US). She has made significant contributions to the field of cancer research, particularly in the treatment of ovarian cancer. Her innovative approach focuses on the use of specific chemical compounds to inhibit the growth of cancer cells.

Latest Patents

Server A Ertem holds a patent for the treatment of ovarian cancer with benzylidenebenzohydrazides. This patent outlines methods for inhibiting the growth of ovarian cancer cells or other serosal cancer cells. The method involves exposing the cells to a benzylidinebenzohydrazide of a specific formula, wherein X can be carbon or nitrogen. This innovative treatment has the potential to improve outcomes for patients suffering from ovarian cancer.

Career Highlights

Server A Ertem is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. Her work at this prestigious center has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of her notable collaborators is Malcolm A Moore, who works alongside her in advancing cancer treatment methodologies. Their combined efforts aim to enhance the understanding and treatment of ovarian cancer.

Conclusion

Server A Ertem's contributions to cancer research, particularly through her patent on benzylidenebenzohydrazides, highlight her commitment to improving cancer treatment. Her work at Memorial Sloan Kettering Cancer Center continues to pave the way for innovative solutions in the fight against ovarian cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…